311 related articles for article (PubMed ID: 30179534)
1. Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches.
Bonn-Miller MO; ElSohly MA; Loflin MJE; Chandra S; Vandrey R
Int Rev Psychiatry; 2018 Jun; 30(3):277-284. PubMed ID: 30179534
[TBL] [Abstract][Full Text] [Related]
2. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
3. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
.
Marcu J
Dialogues Clin Neurosci; 2020 Sep; 22(3):289-293. PubMed ID: 33162772
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids: for better and for worse
.
Thibaut F; Hoehe MR
Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of cannabinoids in combination cancer therapy.
Malhotra P; Casari I; Falasca M
Adv Biol Regul; 2021 Jan; 79():100774. PubMed ID: 33422460
[TBL] [Abstract][Full Text] [Related]
7. A regulatory take on cannabis and cannabinoids for medicinal use in the European Union.
Lipnik-Štangelj M; Razinger B
Arh Hig Rada Toksikol; 2020 Mar; 71(1):12-18. PubMed ID: 32597142
[TBL] [Abstract][Full Text] [Related]
8. Should Oncologists Recommend Cannabis?
Abrams DI
Curr Treat Options Oncol; 2019 Jun; 20(7):59. PubMed ID: 31161270
[TBL] [Abstract][Full Text] [Related]
9. The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling.
O'Connor SM; Lietzan E
Am Univ Law Rev; 2019; 68(3):823-925. PubMed ID: 30919712
[TBL] [Abstract][Full Text] [Related]
10. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
11. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids: Medical implications.
Schrot RJ; Hubbard JR
Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health.
Liberale L; Montecucco F; Carbone F
Adv Exp Med Biol; 2021; 1308():249-255. PubMed ID: 33861448
[TBL] [Abstract][Full Text] [Related]
15. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization.
Jordan A; Sherazi A; Flewelling AJ; Northrup V; Naseemuddin A; Shea JL
Int J Drug Policy; 2022 May; 103():103629. PubMed ID: 35228057
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP
Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
[TBL] [Abstract][Full Text] [Related]
17. The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms.
Hazekamp A; Ware MA; Muller-Vahl KR; Abrams D; Grotenhermen F
J Psychoactive Drugs; 2013; 45(3):199-210. PubMed ID: 24175484
[TBL] [Abstract][Full Text] [Related]
18. A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Potter DJ
Drug Test Anal; 2014; 6(1-2):31-8. PubMed ID: 24115748
[TBL] [Abstract][Full Text] [Related]
19. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Peschel W; Politi M
Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837
[TBL] [Abstract][Full Text] [Related]
20. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
